Literature DB >> 3195994

Vancomycin concentrations in infected and noninfected human bone.

A L Graziani1, L A Lawson, G A Gibson, M A Steinberg, R R MacGregor.   

Abstract

Concentrations of vancomycin in bones of 14 patients undergoing total hip arthroplasty (group 1) and 5 patients with osteomyelitis (group 2) were studied. Group 1 received vancomycin, 15 mg/kg intravenously, 1 h prior to anesthesia. Group 2 received doses adjusted to achieve peak levels in serum of 20 to 30 micrograms/ml and trough levels of less than 12 micrograms/ml; bone specimens were collected during surgical debridement. The specimens were pulverized and eluted into phosphate buffer, and the supernatants were analyzed for vancomycin content by fluorescence polarization immunoassay. In group 1, vancomycin was detectable in all cancellous specimens with a mean concentration of 2.3 +/- 4.0 micrograms/g (range, 0.5 to 16 micrograms/g); 10 of 14 cortical specimens had detectable vancomycin; the mean cortical concentration was 1.1 +/- 0.8 micrograms/g (range, not detectable to 2.6 micrograms/g). In group 2, vancomycin was detectable in only two of five cortical bone specimens (mean concentration, 5.9 +/- 3.5 micrograms/g). Cancellous bone was obtained in one patient; the vancomycin concentration was 3.6 micrograms/g. In most patients the vancomycin levels in bones were higher than the MIC for susceptible staphylococci following single prophylactic doses. In the few infected patients studied, penetration was variable and deserves further study.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3195994      PMCID: PMC175859          DOI: 10.1128/AAC.32.9.1320

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Antibiotic-tolerant Staphylococcus aureus.

Authors:  C Watanakunakorn
Journal:  J Antimicrob Chemother       Date:  1978-11       Impact factor: 5.790

2.  Bone concentrations of antimicrobial agents after parenteral administration.

Authors:  J D Smilack; W H Flittie; T W Williams
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

3.  The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement.

Authors:  B A Cunha; H R Gossling; H S Pasternak; C H Nightingale; R Quintiliani
Journal:  J Bone Joint Surg Am       Date:  1977-10       Impact factor: 5.284

4.  A conversation with William L. Bargar, MD. Custom cementless total hip replacement.

Authors:  W L Bargar
Journal:  Orthop Rev       Date:  1987-01

5.  Cefamandole bone diffusion in patients undergoing total hip replacement.

Authors:  A J Roncoroni; C Manuel; C Nedjar; J Bauchet; D Mariani
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

6.  Antibiotic bone penetration. Concentrations of methicillin and clindamycin phosphate in human bone taken during total hip replacement.

Authors:  D J Schurman; B L Johnson; G Finerman; H C Amstutz
Journal:  Clin Orthop Relat Res       Date:  1975-09       Impact factor: 4.176

7.  Bacteriophage types and antibiotic susceptibility of Staphylococcus aureus.

Authors:  J Klastersky; J Beumer; D Daneau
Journal:  Appl Microbiol       Date:  1971-12

8.  Cefazolin concentrations in bone and synovial fluid.

Authors:  D J Schurman; H P Hirshman; G Kajiyama; K Moser; D S Burton
Journal:  J Bone Joint Surg Am       Date:  1978-04       Impact factor: 5.284

9.  The penetration of cefazolin, erythromycin and methicillin into human bone tissue.

Authors:  T S Sørensen; H Colding; E Schroeder; V T Rosdahl
Journal:  Acta Orthop Scand       Date:  1978-12

10.  Antibiotic concentrations in pus and bone of children with osteomyelitis.

Authors:  T R Tetzlaff; J B Howard; G H McCraken; E Calderon; J Larrondo
Journal:  J Pediatr       Date:  1978-01       Impact factor: 4.406

View more
  34 in total

Review 1.  Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit.

Authors:  A S Haddadin; S A Fappiano; P A Lipsett
Journal:  Postgrad Med J       Date:  2002-07       Impact factor: 2.401

Review 2.  Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases.

Authors:  P S McKinnon; S L Davis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-10       Impact factor: 3.267

3.  Penetration of vancomycin in uninfected sternal bone.

Authors:  L Massias; C Dubois; P de Lentdecker; O Brodaty; M Fischler; R Farinotti
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

4.  Long-term methicillin-resistant Staphylococcus aureus bacteremia persisting for more than 2 weeks: risk factors and outcomes.

Authors:  Yu-Mi Lee; Yong Pil Chong; Minjeong Kim; Yewon Eom; Eun Sil Kim; Miyoung Kim; Ki-Ho Park; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-23       Impact factor: 3.267

5.  Ceftobiprole: First reported experience in osteomyelitis.

Authors:  A Macdonald; G Dow
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

6.  Prospective Cohort Study of the Tolerability of Prosthetic Joint Infection Empirical Antimicrobial Therapy.

Authors:  Claire Triffault-Fillit; Florent Valour; Ronan Guillo; Michel Tod; Sylvain Goutelle; Sébastien Lustig; Michel-Henry Fessy; Christian Chidiac; Tristan Ferry
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 7.  Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections.

Authors:  Christopher Giuliano; Christopher Giulano; Krystal K Haase; Ronald Hall
Journal:  Expert Rev Anti Infect Ther       Date:  2010-01       Impact factor: 5.091

Review 8.  Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.

Authors:  Jason G Newland; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 9.  Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.

Authors:  Nikolas J Onufrak; Alan Forrest; Daniel Gonzalez
Journal:  Clin Ther       Date:  2016-07-20       Impact factor: 3.393

Review 10.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.